Zurich Cantonal Bank
LENZ

Zurich Cantonal Bank’s LENZ Therapeutics LENZ Stock Holding History

Zurich Cantonal Bank’s Portfolio LENZ Stock Details LENZ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-267
Closed -$4.27K – 3435
2025
Q4 		$4.27K Buy
+267
New +$7.78K ﹤0.01% 2504

Other funds holding LENZ

RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
AWG
Alpha Wave Global New York $791M AUM 113.77% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
VVM
Versant Venture Management San Francisco, California $141M AUM 190.82% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Squarepoint
Squarepoint New York $85.1B AUM 20.93% 1-Year Est. Return
Aberdeen Group
Aberdeen Group Edinburgh, United Kingdom $61.9B AUM 29.81% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
7IH
72 Investment Holdings Stamford, Connecticut $49.6M AUM 684.72% 1-Year Est. Return

Zurich Cantonal Bank's LENZ Position: Q1 2026 in Review

Zurich Cantonal Bank opened a new position in LENZ Therapeutics (LENZ) in Q1 2026: 6,099 shares worth $55.8K. The stake represents ﹤0.01% of the portfolio and ranks #2434 among its holdings. This is a return to the name: Zurich Cantonal Bank previously reported a position in LENZ as recently as Q3 2025.

Zurich Cantonal Bank first reported a position in LENZ in Q1 2025 and has held it in 4 quarters since. 145 funds tracked by Wall St. Rank hold LENZ as of Q1 2026.

  • Zurich Cantonal Bank held 6,099 shares of LENZ Therapeutics worth $55.8K as of Q1 2026.
  • LENZ Therapeutics was a new Zurich Cantonal Bank position in Q1 2026.
  • LENZ Therapeutics made up ﹤0.01% of Zurich Cantonal Bank's portfolio in Q1 2026, its #2434 holding.
  • Zurich Cantonal Bank first reported a position in LENZ Therapeutics in Q1 2025 and has held it in 4 quarters since.
  • 145 funds tracked by Wall St. Rank held LENZ Therapeutics as of Q1 2026.

Based on Zurich Cantonal Bank's 13F filing for Q1 2026, filed 15 May 2026.